Breaking News

c-Lecta Launches GMP-Grade Version of Denarase High Salt

Efficiently and cost-effectively removes nucleic acids in biomanufacturing processes that benefit from elevated salt levels.

Author Image

By: Charlie Sternberg

Associate Editor

c-LEcta, an international supplier of enzymes for the biopharmaceutical industry, has launched the GMP-grade version of Denarase High Salt, a strategic extension of its Denarase portfolio. The GMP-grade version of Denarase High Salt is intended to serve customers with clinical and commercial stage processes that require compliance with the highest quality standards. Denarase High Salt is utilized for the removal of DNA/RNA impurities in biopharmaceutical production. It is an engineered ver...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters